Alkem Laboratories Limited is a pharmaceutical company that is involved in the research, production, and distribution of pharmaceutical and nutraceutical products both in India and internationally. The company specializes in offering a wide range of products including branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals. These products cater to various therapeutic areas such as anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology. Additionally, Alkem Laboratories Limited also manufactures vitamins, minerals, and nutrients, as well as pain analgesic, anti-diabetic, and neurology products. The company further extends its product portfolio by providing pregnancy detection kits and condoms. Established in 1973, Alkem Laboratories Limited is headquartered in Mumbai, India.
Navigation section
Alkem Laboratories Limited
- 5,490.00 30.55(0.56%) 5,501.45 43.65(0.80%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 5,425.05 5,428.20 | 5,516.80 5549.95 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 4,407.05 (04-Jun-2024) 4,409.90 (04-Jun-2024) | 6,439.90 (13-Sep-2024) 6,440.00 (17-Sep-2024) |
- Open
- 5,474.00 5,549.95
- Previous Close
- 5,459.45 5,457.80
- Volume
- 0.79
- Total Traded value
- 43.63 (₹ Lakhs)
- Upper circuit
- 6,005.35 5,555.20
- Lower circuit
- 4,913.50 4,545.20
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 1 | 0 |
| Bid Price | Quantity |
|---|---|
| 5,489.95 | 1.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 1 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹656.41 Cr |
| PE Ratio (TTM): | 31.17 |
| PB Ratio: | 5.59 |
| Industry P/E: | 29.50 |
| Debt to Equity: | - |
| ROE: | 17.93 |
| EPS (TTM): | 176.48 |
| Book Value: | 0.00 |
| Face Value: | 2.00 |
Financials
| Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | |
|---|---|---|---|---|---|
| Revenue | 145.78 Cr | 74.75 Cr | 68.02 Cr | 570.82 Cr | 2,253.17 Cr |
| Profit | 7.99 Cr | 13.89 Cr | 1.83 Cr | 11.40 Cr | 271.44 Cr |
| Expense | 137.42 Cr | 55.33 Cr | 65.46 Cr | 556.77 Cr | 1,998.95 Cr |
| Comprehensive income | 7.99 Cr | 13.92 Cr | 1.83 Cr | 9.91 Cr | 269.87 Cr |
| EPS | 1.20 | 0.18 | 1.57 | 1.71 | 22.70 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Alkem Laboratories Limited | Dec, 2015 Dec, 2015 | Pharmaceuticals Pharmaceuticals | ALKEM ALKEM |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Alkem Laboratories Limited FAQ's
What is the range of today's stock performance for Alkem Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 5,425.05 on the NSE (National Stock Exchange) to a maximum of 5,516.80. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 5,428.20 to a high of 5,549.95.
What are the 52-week low and high values for Alkem Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 4,407.05 (occurred on 04-Jun-2024) and a high of 6,439.90 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,409.90 (on 04-Jun-2024), and the 52-week high is 6,440.00 (on 17-Sep-2024).
What was the opening and previous closing prices for Alkem Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 4,407.05 (occurred on 04-Jun-2024) and a high of 6,439.90 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,409.90 (on 04-Jun-2024), and the 52-week high is 6,440.00 (on 17-Sep-2024).
What is the total volume and traded value for Alkem Laboratories Limited for the day?
The total volume is 1, and the total traded value is 43.63 (₹ Lakhs).
What are the upper and lower circuit limits for Alkem Laboratories Limited?
The upper circuit limit is 6,005.35, and the lower circuit limit is 4,913.50.
What is the market cap and PE ratio for Alkem Laboratories Limited?
The market cap is ₹656.41 Cr, and the PE ratio (TTM) is 30.21.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Alkem Laboratories Limited?
ROE is 17.93, EPS is 176.48, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Alkem Laboratories Limited?
In Jun 2023, Revenue is ₹1457813000.00, and Profit is ₹79888000.00. In Jun 2023, Revenue is ₹747466000.00, and Profit is ₹138858000.00.
When was Alkem Laboratories Limited listed, and what industry does it belong to?
The company, Alkem Laboratories Limited, was listed in Dec 2015 and belongs to the Pharmaceuticals industry. Its NSE symbol is ALKEM.
What is the current shareholding pattern of the Alkem Laboratories Limited?
As of latest available update, promoters hold 56.74%, the public holds 43.26%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
